2005
DOI: 10.1523/jneurosci.2565.04.2005
|View full text |Cite
|
Sign up to set email alerts
|

Age-Dependent Enhancement of Hippocampal Long-Term Potentiation and Impairment of Spatial Learning through the Rho-Associated Kinase Pathway in Protein Tyrosine Phosphatase Receptor Type Z-Deficient Mice

Abstract: Although protein tyrosine phosphatases (PTPs) are expressed abundantly in the brain, their roles in synaptic plasticity have not been well elucidated. In this study, we have examined the physiological functions of Ptprz, which is a receptor-type PTP expressed predominantly in the brain as a chondroitin sulfate proteoglycan. We have examined phenotypes of mutant mice deficient in Ptprz using electrophysiological, pharmacological, and behavioral approaches. Mutant mice exhibit enhanced long-term potentiation (LT… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
42
0

Year Published

2007
2007
2018
2018

Publication Types

Select...
6
1
1

Relationship

0
8

Authors

Journals

citations
Cited by 68 publications
(42 citation statements)
references
References 53 publications
(76 reference statements)
0
42
0
Order By: Relevance
“…This functional property appears to be mostly core protein-dependent in versican V0, V1 and V2 (Dutt, Stöckli and Zimmermann unpublished;Niederöst et al 1999;Schmalfeldt et al 2000;), neurocan and phosphacan (Maeda and Noda 1996), whereas no inhibition of brevican (Yamada et al 1997a) and cartilage-derived aggrecan (Snow et al 1990) has been detected after chondroitinase ABC digestion. Notably, we also observed two-to threefold reductions, but never an abolition of the inhibitory capacity of versican V2 in stripe choice experiments after complete glycosaminoglycan-removal (Schmalfeldt et al Table 2 Available ECM-knockout mouse strains LTP Hippocampal long-term potentiation, EAE experimental autoimmune encephalomyelitis, PNN perineuronal net, ND not described Brevican (Brakebusch et al 2002); neurocan (Zhou et al 2001); versican (Mjaatvedt et al 1998); aggrecan ; RPTP-/phosphacan (Harroch et al 2000(Harroch et al , 2002Niisato et al 2005); TnR (Bruckner et al 2000;Freitag et al 2003;Haunso et al 2000;Montag-Sallaz and Montag 2003;Saghatelyan et al 2004;Weber et al 1999); TnC (Evers et al 2002;Forsberg et al 1996;Fukamauchi et al 1996;Kiernan et al 1999;Saga et al 1992); HAPLN1/Crtl1 (Watanabe and Yamada 1999); HAS2 (Camenisch et al 2000); HAS3 (Bai et al 2005) . This moderate decrease might be related to the partial collapse of the extended core protein structure after elimination of the highly negatively charged chondroitin sulfate side chains.…”
Section: Axon Growth Inhibitionmentioning
confidence: 67%
“…This functional property appears to be mostly core protein-dependent in versican V0, V1 and V2 (Dutt, Stöckli and Zimmermann unpublished;Niederöst et al 1999;Schmalfeldt et al 2000;), neurocan and phosphacan (Maeda and Noda 1996), whereas no inhibition of brevican (Yamada et al 1997a) and cartilage-derived aggrecan (Snow et al 1990) has been detected after chondroitinase ABC digestion. Notably, we also observed two-to threefold reductions, but never an abolition of the inhibitory capacity of versican V2 in stripe choice experiments after complete glycosaminoglycan-removal (Schmalfeldt et al Table 2 Available ECM-knockout mouse strains LTP Hippocampal long-term potentiation, EAE experimental autoimmune encephalomyelitis, PNN perineuronal net, ND not described Brevican (Brakebusch et al 2002); neurocan (Zhou et al 2001); versican (Mjaatvedt et al 1998); aggrecan ; RPTP-/phosphacan (Harroch et al 2000(Harroch et al , 2002Niisato et al 2005); TnR (Bruckner et al 2000;Freitag et al 2003;Haunso et al 2000;Montag-Sallaz and Montag 2003;Saghatelyan et al 2004;Weber et al 1999); TnC (Evers et al 2002;Forsberg et al 1996;Fukamauchi et al 1996;Kiernan et al 1999;Saga et al 1992); HAPLN1/Crtl1 (Watanabe and Yamada 1999); HAS2 (Camenisch et al 2000); HAS3 (Bai et al 2005) . This moderate decrease might be related to the partial collapse of the extended core protein structure after elimination of the highly negatively charged chondroitin sulfate side chains.…”
Section: Axon Growth Inhibitionmentioning
confidence: 67%
“…RPTP/phosphacan is required for normal nervous system development and function (32,33,35). Whether O-mannosylation of this protein contributes to its function has been more difficult to determine, due to the predominating role of another highly mannosylated glycoprotein (␣-DG) in CMDs.…”
Section: Discussionmentioning
confidence: 99%
“…Recent work detailed the structures of glycans carrying the HNK-1 epitope on RPTP/phosphacan and showed that this protein is the main carrier of unique O-mannose-linked terminal HNK-1 glycans (62). HNK-1 glycans have a role in learning and memory (63,64), and RPTP/phosphacan knock-out mice have been shown to exhibit parallel deficits (35), suggesting that O-mannosyl glycans may be responsible for these changes.…”
Section: Discussionmentioning
confidence: 99%
“…One of the first and most influential studies which evaluated the role of PNNs in the experience-dependent plasticity is the one conducted by Pizzorusso and colleagues performance (Niisato et al, 2005). Moreover, it has been found that genetic deletion of link proteins also enhances plasticity mechanisms underlying ocular dominance .…”
Section: Pnns In Learning and Memorymentioning
confidence: 99%
“…performance (Niisato et al, 2005). Moreover, it has been found that genetic deletion of link proteins also enhances plasticity mechanisms underlying ocular dominance .…”
Section: Pnns In Learning and Memorymentioning
confidence: 99%